"However, I can point to an aspect of the LFB deal that you may be overlooking: that FVIIa is one the most promising plasma proteins" It is also one of the most difficult to succeed at. Does anyone not married to this stock care to predict the chances of GTC' success in this arena? at a cost of 20% of the entire company?